{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:40:48Z","timestamp":1793403648074,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370331"],"award-info":[{"award-number":["81370331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clinthera.2022.06.010","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T23:45:59Z","timestamp":1658792759000},"page":"1071-1092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Apolipoprotein B Displays Superior Predictive Value Than Other Lipids for Long-Term Prognosis in Coronary Atherosclerosis Patients and Particular Subpopulations: A Retrospective Study"],"prefix":"10.1016","volume":"44","author":[{"given":"Chunyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4329-5940","authenticated-orcid":false,"given":"Zhenyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2022.06.010_bib0001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11886-020-01323-z","article-title":"Non-HDL Cholesterol or ApoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?","volume":"22","author":"Langlois","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10408363.2013.847897","article-title":"ApoB versus Non-HDL-Cholesterol: Diagnosis and Cardiovascular Risk Management","volume":"50","author":"de Nijs","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0003","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pathol.2018.11.006","article-title":"Non-HDL-Cholesterol and Apolipoprotein B Compared with LDL-Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment","volume":"51","author":"Carr","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0004","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1194\/jlr.R083451","article-title":"Lipid Transfer Proteins in the Assembly of ApoB-Containing Lipoproteins","volume":"59","author":"Sirwi","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0005","unstructured":"ApoB - PubMed https:\/\/pubmed.ncbi.nlm.nih.gov\/31070997\/ (accessed 2021 -08 -08)."},{"key":"10.1016\/j.clinthera.2022.06.010_bib0006","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/db08-1794","article-title":"Apolipoprotein B but Not LDL Cholesterol Is Associated with Coronary Artery Calcification in Type 2 Diabetic Whites","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0007","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9149(03)00262-5","article-title":"Concordance\/Discordance between Plasma Apolipoprotein B Levels and the Cholesterol Indexes of Atherosclerotic Risk","volume":"91","author":"Sniderman","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4065\/mcp.2009.0517","article-title":"Using Apolipoprotein B to Manage Dyslipidemic Patients: Time for a Change?","volume":"85","author":"Harper","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0009","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.atherosclerosis.2012.08.039","article-title":"Discordance Analysis of Apolipoprotein B and Non-High Density Lipoprotein Cholesterol as Markers of Cardiovascular Risk in the INTERHEART Study","volume":"225","author":"Sniderman","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2004.07.019","article-title":"Apolipoprotein B Determines Risk for Recurrent Coronary Events in Postinfarction Patients with Metabolic Syndrome","volume":"177","author":"Corsetti","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0011","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1373\/clinchem.2008.118356","article-title":"AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices","volume":"55","author":"Contois","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0012","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"European Atherosclerosis Society Consensus Panel. The Polygenic Nature of Hypertriglyceridaemia: Implications for Definition, Diagnosis, and Management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3803\/EnM.2020.35.2.351","article-title":"Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity","volume":"35","author":"Han","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0014","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1573403X15666191111123622","article-title":"Assessing Cardiovascular Risk in Patients with Diabetes: An Update","volume":"16","author":"Damaskos","year":"2020","journal-title":"Curr Cardiol Rev"},{"issue":"4","key":"10.1016\/j.clinthera.2022.06.010_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/10641963.2015.1131286","article-title":"Postmenopausal Hypertension, Abdominal Obesity, Apolipoprotein and Insulin Resistance","volume":"38","author":"Ben Ali","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0016","unstructured":"Prognostic implications of calculated Apo-lipoprotein B in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut-points - PubMed https:\/\/pubmed.ncbi.nlm.nih.gov\/33942349\/ (accessed 2021 -08 -08)."},{"key":"10.1016\/j.clinthera.2022.06.010_bib0017","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1253\/circj.CJ-19-1097","article-title":"Apolipoprotein B\/A-I Ratio Predicts Lesion Severity and Clinical Outcomes in Diabetic Patients With Acute Coronary Syndrome","volume":"84","author":"Liu","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0018","first-page":"612","article-title":"Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000759","article-title":"Relations of Change in Plasma Levels of LDL-C, Non-HDL-C and ApoB with Risk Reduction from Statin Therapy: A Meta-Analysis of Randomized Trials","volume":"3","author":"Thanassoulis","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0020","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC Scientific Document Group. 2019 ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0022","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2010.50","article-title":"Diagnosis and Treatment of Apolipoprotein B Dyslipoproteinemias","volume":"6","author":"Sniderman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2022.06.010_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2022.06.010_bib0024","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2019.12.005","volume":"294","author":"Nordestgaard","year":"2020","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.clinthera.2022.06.010_bib0025","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2012.07.007","article-title":"Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials","volume":"110","author":"Robinson","year":"2012","journal-title":"Am J Cardiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822002223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822002223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:57:11Z","timestamp":1758963431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291822002223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0149291822002223"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.06.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein B Displays Superior Predictive Value Than Other Lipids for Long-Term Prognosis in Coronary Atherosclerosis Patients and Particular Subpopulations: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}